title: Cilengitide in glioblastoma: when did it fail?
authors.affiliation: Aix-Marseille University, AP-HM, Department of Neuro-Oncology, CHU Timone, 13005 Marseille, France. Electronic address: olivier.chinot@ap-hm.fr.
authors.forename: Olivier L
authors.initials: OL
authors.lastname: Chinot
mesh_terms: D001932:Brain Neoplasms / Q000188:drug therapy*; D015254:DNA Modification Methylases / Q000235:genetics*; D045643:DNA Repair Enzymes / Q000235:genetics*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012910:Snake Venoms / Q000627:therapeutic use*; D000077204:Temozolomide; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: D012910:Snake Venoms; D025521:Tumor Suppressor Proteins; C422910:Cilengitide; D003606:Dacarbazine; D015254:DNA Modification Methylases; C515491:MGMT protein, human; D045643:DNA Repair Enzymes; D000077204:Temozolomide